Literature DB >> 24116718

Tolerance to COX-2 inhibitors in children with hypersensitivity to nonsteroidal anti-inflammatory drugs.

J L Corzo1, M A Zambonino, C Muñoz, C Mayorga, G Requena, A Urda, C Gallego, M Blanca, M J Torres.   

Abstract

BACKGROUND: Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) can affect children, with the mechanism proposed being inhibition of the cyclooxygenase enzyme-1 (COX-1). In these patients nonchemically related NSAIDs, including COX-2 inhibitors, can induce the reaction, hampering treatment of fever and inflammatory processes.
OBJECTIVES: To analyse retrospectively tolerance to etoricoxib, a selective COX-2 inhibitor, and to meloxicam, a preferential COX-2 inhibitor, in children with hypersensitivity to NSAIDs.
METHODS: Clinical records of children (aged 1-14 years) diagnosed with hypersensitivity reactions to NSAIDs from January 2006 to January 2013 were included. The diagnosis was confirmed by oral drug provocation test (DPT) with the culprit NSAIDs and acetylsalicylic acid (ASA). Tolerance to paracetamol, etoricoxib and meloxicam was also evaluated.
RESULTS: The study included 41 children with a positive DPT with ASA and the culprit NSAID. DPT with paracetamol and etoricoxib was negative in all children, although two (4.9%) children developed a reaction after the administration of meloxicam.
CONCLUSIONS: These data indicate that both etoricoxib and meloxicam are good alternatives for treatment in older children with hypersensitivity to NSAIDs.
© 2013 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24116718     DOI: 10.1111/bjd.12674

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  4 in total

1.  Tolerance to etoricoxib in children with nonsteroidal anti-inflammatory drug hypersensitivity.

Authors:  Wenyin Loh; Hwee Hoon Lim; Rajeshwar Rao; Anne Goh; Lin Xin Ong; Wen Chin Chiang
Journal:  Asia Pac Allergy       Date:  2015-01-28

Review 2.  Pro and Contra: Provocation Tests in Drug Hypersensitivity.

Authors:  Ozge Soyer; Umit Murat Sahiner; Bulent Enis Sekerel
Journal:  Int J Mol Sci       Date:  2017-07-04       Impact factor: 5.923

3.  Drug Allergy in Children: What Should We Know?

Authors:  Ji Soo Park; Dong In Suh
Journal:  Clin Exp Pediatr       Date:  2019-11-12

Review 4.  NSAID Hypersensitivity in the Pediatric Population: Classification and Diagnostic Strategies.

Authors:  Ozlem Cavkaytar; Mustafa Arga
Journal:  J Asthma Allergy       Date:  2022-09-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.